PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

TraceLink Joins Irish Medicines Verification Organization (IMVO) Serialization Pilot for Pharmacies and Clinics

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better pati...
Continue Reading →
News

Myanmar, S. Korea to collaborate in health sector

Myanmar and South Korea have been stepping up cooperation in the health sector including joint medical research. Myanmar's Yangon University of Pharmacy and South Ko...
Continue Reading →
News

Almac Group Launches GMP High Throughput Peptide Manufacturing Service

Almac Group, the global contract development and manufacturing organisation, is delighted to announce the successful MHRA registration of its High Throughput GMP Pep...
Continue Reading →
News

Merck’s BioReliance® Product Characterization Services Help Ensure Purity, Safety and Efficacy

Provides critical information, analytics to help manufacturers make data-driven decisions to inform process development, mitigate risk and streamline regulatory dev...
Continue Reading →
News

Pfizer announces EC approval of its oncology biosimilar

The European Commission decision marks the approval of Pfizer’s first therapeutic oncology bio-similar. Pfizer Inc. has announced that the European Commission (EC) h...
Continue Reading →
News

NUS group develops novel drug against liver cancer

This landmark discovery opens door for more effective treatment of liver cancer with less side effects. A research team led by scientists from the Cancer Instit...
Continue Reading →
News

Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its-kind treatment specifically designed for migraine prevention

Novartis announced today that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine d...
Continue Reading →
News

Turkish Pharmaceutical Industry Leader, Abdi Ibrahim, Selects rfxcel for FMD Compliance

Abdi Ibrahim, the Turkish pharmaceutical industry leader, has carefully selected rfxcel to implement and support new compliance management and serialisatio...
Continue Reading →
News

KIEFEL REGROUPS ITS PACKAGING ACTIVITIES

Following several acquisitions and steep organic growth in recent years, KIEFEL GmbH, the Germany-based specialist for plastic film material processing machines, is ...
Continue Reading →
News

Merck, InnoCore Pharma team up for drug delivery platform

The new proprietary technology developed by InnoCore Pharmaceuticals allows the development of injectable sustained release biological formulations with conserved bi...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026